Company news

CareDx, Inc. news in 2022

CareDx, Inc.'s news releases, calls and decks from 2022, newest first.

View company

New ISHLT Guidelines Support Use of CareDx’s HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients

December 20, 2022

CareDx Announces $50 Million Stock Repurchase Program

December 5, 2022

Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance

November 30, 2022

CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community

November 10, 2022

CareDx To Participate in Upcoming Investor Conferences

November 3, 2022

CareDx Reports Third Quarter 2022 Results

November 2, 2022

CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week

November 1, 2022

Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients

October 31, 2022

CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System

October 26, 2022

CareDx to Report Third Quarter 2022 Financial Results

October 25, 2022

CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients

October 25, 2022

CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting

October 24, 2022

CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care

September 28, 2022

Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions

September 26, 2022

CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List

September 25, 2022

CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference

September 18, 2022

CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone

September 13, 2022

CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society

September 11, 2022

CareDx and MOTTEP Co-Host Health Equity Summit

August 10, 2022

CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App

August 3, 2022

CareDx Reports Second Quarter 2022 Results

August 3, 2022

CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care

August 1, 2022

CareDx to Report Second Quarter 2022 Financial Results

July 27, 2022

CareDx Demonstrates Industry-Leading Commitment to Advancing Transplant Innovation as Distinguished Founder’s Circle Sponsor for the 2022 American Society of Transplant Surgeons Symposium

July 27, 2022

CareDx Lead Sponsor for 2022 Donate Life Transplant Games

June 27, 2022

CareDx The Transplant Company Releases Inaugural Environmental, Social and Governance Report

June 20, 2022

CareDx To Participate in Upcoming Jefferies Healthcare Conference

June 1, 2022

CareDx Leads Transplant Innovation with AiKidney, an AI Clinical Decision Support Tool for Predicting Allograft Rejection Risk

June 1, 2022

CareDx Innovation Showcased in Record-Breaking Number of Scientific Abstracts with Over 50 Presented at 2022 Transplant Congress

May 31, 2022

CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation

May 23, 2022

CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction

May 17, 2022

In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx

May 16, 2022

CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference

May 10, 2022

CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection

May 4, 2022

CareDx Reports First Quarter 2022 Results

May 4, 2022

CareDx Extends Artificial Intelligence Leadership to Heart Transplantation

April 27, 2022

CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award

April 27, 2022

CareDx to Report First Quarter 2022 Financial Results

April 26, 2022

CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings

April 21, 2022

CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation

April 20, 2022

CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting

April 19, 2022

CareDx Reports Over 200,000 Heart Transplant Patient Results Served

April 13, 2022

CareDx, the Leading Sponsor of UNOS Transplant Management Forum, Demonstrates the Value of Digital Solutions to Improve Pre-Transplant Patient Referral and Waitlisting Workflow

April 10, 2022

CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance

April 5, 2022

CareDx Partners with the European Society for Organ Transplantation to Provide Clinical Evidence Supporting the Use of AlloSeq cfDNA with European Transplant Healthcare Professionals

March 29, 2022

CareDx Partners with HeartBrothers Foundation to Help Patients Living with Heart Failure and Heart Transplant

March 28, 2022

CareDx’s AlloCare App Now Integrated with TxAccess to Help Pre-Transplant Patients Navigate the Waitlist Process

March 23, 2022

UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community

March 22, 2022

CareDx Announces XenoSure and XenoMap

March 22, 2022

CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation

March 15, 2022

Older news releases →

Calls in 2022

Decks in 2022